Biomarkers in Medicine

简称 BIOMARK MED ·ENGLAND ·出版周期 Bimonthly ·年均收录 103 篇

2.1

最新影响因子

4.00%

自引率

一般

投稿难度

较慢,6-12周

审稿周期

期刊简介

Biomarkers in Medicine是一本专注于生物标志物研究的国际学术期刊，ISSN号为1752-0363，由Future Medicine Ltd出版，出版地为英国，出版周期为月刊。该期刊的影响因子根据年份有所不同，最新数据需查询官方来源，目前为非开放获取（非OA）期刊，被SCI收录，中科院分区情况需根据最新分区表确认。杂志的发文特点集中于生物标志物的发现、验证及其在疾病诊断、治疗和预后中的应用，涵盖肿瘤学、心血管疾病、神经科学和免疫学等多个研究领域。其质量较高，审稿流程严格，但作为专业期刊，读者群体相对局限，可能存在投稿竞争激烈的情况，风险在于影响因子波动及投稿接受率的不确定性。总体而言，该杂志是生物标志物研究领域的重要平台，适合相关领域的学者投稿和阅读。

影响因子趋势

近期发表

Looking beyond a single blood eosinophil count in COPD 2026-08-31

Meta-analysis of the relationship between preoperative systemic immune inflammation index and prognosis of patients with biliary tract cancer 2026-08-20

Diagnostic and prognostic value of deregulated miR-493-5p in children with severe pneumonia 2026-08-21

Recent advances in cardiovascular biomarkers: innovations in early detection, risk prediction, and treatment monitoring 2026-08-05

Analytical validity of CD20 as a biomarker in breast cancer patients using tissue microarrays and whole slide sections 2026-08-07

Gene–virus interaction between IFN-γ rs2069705 polymorphism and Epstein–Barr virus in breast cancer susceptibility among Egyptian women 2026-08-11

Inflammatory burden index and prognostic outcomes in gastrointestinal cancer: a meta-analysis 2026-08-06

Circ_0024085 and circ_0000339 as potential biomarkers for the diagnosis of ankylosing spondylitis 2026-08-17

Coagulation factor levels as prognostic biomarkers: differential profiles in pulmonary versus extrapulmonary sepsis-induced ARDS 2026-08-17

Serum LDH, eosinophils, and IgE in atopic dermatitis severity: a retrospective study 2026-07-30